BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32858111)

  • 21. Indispensability of chemotherapy in estrogen receptor-negative early breast cancer in elderly women with diabetes mellitus.
    Jia X; Hong Q; Cheng J; Li J; Wang Y; Mo M; Shao Z; Shen Z; Liu G
    Diabetes Technol Ther; 2015 Apr; 17(4):248-54. PubMed ID: 25781236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative CA19-9 levels predict disease-free survival and overall survival in pancreatic adenocarcinoma patients after resection.
    Guan S; Chen Y; Han Q; Deng G; Wang Y; Shi Y; Dai G
    Transl Cancer Res; 2019 Jun; 8(3):811-820. PubMed ID: 35116819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does diabetes mellitus have an impact on the prognosis for patients with cervical cancer?
    In Choi J; Chang HK; Lee DW; Lee KH; Park JS; Lee HN
    Gynecol Oncol; 2015 Nov; 139(2):319-23. PubMed ID: 26360017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the prognostic impact of pre- and post-operative CA19-9, SPan-1, and DUPAN-II levels in patients with pancreatic carcinoma.
    Kondo N; Murakami Y; Uemura K; Nakagawa N; Takahashi S; Ohge H; Sueda T
    Pancreatology; 2017; 17(1):95-102. PubMed ID: 27746094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: a retrospective analysis.
    Amin S; Baine M; Meza J; Lin C
    BMC Cancer; 2020 Jun; 20(1):538. PubMed ID: 32517661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased risk of gastrointestinal malignancy in patients with diabetes mellitus and correlations with anti-diabetes drugs: a nationwide population-based study in Taiwan.
    Chiu CC; Huang CC; Chen YC; Chen TJ; Liang Y; Lin SJ; Chen JW; Leu HB; Chan WL
    Intern Med; 2013; 52(9):939-46. PubMed ID: 23648711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of diabetes mellitus on clinical outcomes in patients undergoing surgical resection for pancreatic cancer: a retrospective, cohort study.
    Hart PA; Law RJ; Frank RD; Bamlet WR; Burch PA; Petersen GM; Rabe KG; Chari ST
    Am J Gastroenterol; 2014 Sep; 109(9):1484-92. PubMed ID: 25070053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High pretreatment serum CA19-9 level predicts a poor prognosis for patients with stage III colon cancer after curative resection and adjuvant chemotherapy.
    Zhou W; Yang F; Peng J; Wang F; Lin Y; Jiang W; Yang X; Li L; Lu Z; Wan D; Pan Z; Fan W
    J Cancer; 2019; 10(16):3810-3818. PubMed ID: 31333798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of diabetes on oncologic outcome of colorectal cancer patients: colon vs. rectal cancer.
    Jeon JY; Jeong DH; Park MG; Lee JW; Chu SH; Park JH; Lee MK; Sato K; Ligibel JA; Meyerhardt JA; Kim NK
    PLoS One; 2013; 8(2):e55196. PubMed ID: 23405123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic and predictive effects of diabetes, hypertension, and coronary artery disease among women on extended adjuvant letrozole: NCIC CTG MA.17.
    Goodwin RA; Jamal R; Booth CM; Goss PE; Eisenhauer EA; Tu D; Shepherd LE
    Eur J Cancer; 2016 May; 58():97-103. PubMed ID: 26986765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of SUVmax and serum carbohydrate antigen 19-9 in pancreatic cancer.
    Zhao JG; Hu Y; Liao Q; Niu ZY; Zhao YP
    World J Gastroenterol; 2014 May; 20(19):5875-80. PubMed ID: 24914348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response.
    Resende U; Cabello C; Ramalho SOB; Zeferino LC
    BMC Cancer; 2019 Jun; 19(1):601. PubMed ID: 31208353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Prognostic Impact of Type 2 Diabetes Mellitus on Early Cervical Cancer in Asia.
    Kuo HY; Lin ZZ; Kuo R; Shau WY; Lai CL; Yang YY; Shao YY; Hsu C; Cheng WF; Cheng AL; Yang JC; Lai MS
    Oncologist; 2015 Sep; 20(9):1051-7. PubMed ID: 26240133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Adjuvant Radiation Therapy With Survival in Patients With Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.
    Harris BN; Pipkorn P; Nguyen KNB; Jackson RS; Rao S; Moore MG; Farwell DG; Bewley AF
    JAMA Otolaryngol Head Neck Surg; 2019 Feb; 145(2):153-158. PubMed ID: 30570645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-Term Prognostic Utility of Coronary CT Angiography in Stable Patients With Diabetes Mellitus.
    Blanke P; Naoum C; Ahmadi A; Cheruvu C; Soon J; Arepalli C; Gransar H; Achenbach S; Berman DS; Budoff MJ; Callister TQ; Al-Mallah MH; Cademartiri F; Chinnaiyan K; Rubinshtein R; Marquez H; DeLago A; Villines TC; Hadamitzky M; Hausleiter J; Shaw LJ; Kaufmann PA; Cury RC; Feuchtner G; Kim YJ; Maffei E; Raff G; Pontone G; Andreini D; Chang HJ; Chow BW; Min J; Leipsic J
    JACC Cardiovasc Imaging; 2016 Nov; 9(11):1280-1288. PubMed ID: 27568114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing the prognostic factors, survival, and recurrence incidence of triple negative breast cancer patients, a single center study in Iran.
    Mousavi SA; Kasaeian A; Pourkasmaee M; Ghavamzadeh A; Alimoghaddam K; Vaezi M; Kamranzadeh Fumani H; Babakhani D; Tavakoli S
    PLoS One; 2019; 14(1):e0208701. PubMed ID: 30608935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer.
    Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Fajkovic H; Babjuk M; Kautzky-Willer A; Bachmann A; Scherr DS; Shariat SF
    BJU Int; 2013 Dec; 112(8):1105-12. PubMed ID: 24053906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy.
    Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
    J Cell Mol Med; 2020 Mar; 24(5):2993-3021. PubMed ID: 31989747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time to CA19-9 nadir: a clue for defining optimal treatment duration in patients with resectable pancreatic ductal adenocarcinoma.
    Reni M; Peretti U; Zanon S; Macchini M; Balzano G; Mazza E; Tamburrino D; Orsi G; Arcidiacono PG; Falconi M; Gianni L
    Cancer Chemother Pharmacol; 2020 Apr; 85(4):641-650. PubMed ID: 32157412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitus.
    Yuan C; Rubinson DA; Qian ZR; Wu C; Kraft P; Bao Y; Ogino S; Ng K; Clancy TE; Swanson RS; Gorman MJ; Brais LK; Li T; Stampfer MJ; Hu FB; Giovannucci EL; Kulke MH; Fuchs CS; Wolpin BM
    J Clin Oncol; 2015 Jan; 33(1):29-35. PubMed ID: 25403204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.